Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippos Koinis

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Scientific Reports|December 16, 2016
Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patientsAthanasios Kotsakis, Filippos Koinis, Afroditi Katsarou, et al.
Breast Cancer Research : BCR|November 30, 2014
Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancyMaria Spiliotaki, Dimitris Mavroudis, Kyriaki Kapranou, et al.
Cancers|May 13, 2026
The HGF/MET Axis in Advanced Prostate Cancer: From Context-Dependent Biology to Biomarker-Driven Therapeutic StrategiesFilippos Koinis, Maria Smaragdi Vlachou, Georgios Nintos, et al.
Journal of Immunology Research|December 2, 2014
A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patientsEleni-Kyriaki Vetsika, Filippos Koinis, Marianthi Gioulbasani, et al.
Therapeutic Advances in Medical Oncology|June 21, 2019
CD8<sup>+</sup> PD-1<sup>+</sup> T-cells and PD-L1<sup>+</sup> circulating tumor cells in chemotherapy-naïve non-small cell lung cancer: towards their clinical relevance?Athanasios Kotsakis, Galatea Kallergi, Despoina Aggouraki, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2014
Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)Filippos Koinis, Aristidis Polyzos, Athina Christopoulou, et al.
Cancers|January 23, 2020
Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate CancerFilippos Koinis, Paul Corn, Nila Parikh, et al.
Plos One|July 19, 2017
Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancerIppokratis Messaritakis, Eleni Politaki, Athanasios Kotsakis, et al.
Cancer Chemotherapy and Pharmacology|August 11, 2018
Prognostic significance of CEACAM5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancerIppokratis Messaritakis, Maria Sfakianaki, Chara Papadaki, et al.
Cancer Chemotherapy and Pharmacology|January 30, 2021
Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(-) breast cancer receiving salvage treatment with everolimus/exemestaneMaria Spiliotaki, Galatea Kallergi, Christos Nikolaou, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Scientific Reports|December 16, 2016
Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patientsAthanasios Kotsakis, Filippos Koinis, Afroditi Katsarou, et al.
Breast Cancer Research : BCR|November 30, 2014
Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancyMaria Spiliotaki, Dimitris Mavroudis, Kyriaki Kapranou, et al.
Cancers|May 13, 2026
The HGF/MET Axis in Advanced Prostate Cancer: From Context-Dependent Biology to Biomarker-Driven Therapeutic StrategiesFilippos Koinis, Maria Smaragdi Vlachou, Georgios Nintos, et al.
Journal of Immunology Research|December 2, 2014
A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patientsEleni-Kyriaki Vetsika, Filippos Koinis, Marianthi Gioulbasani, et al.
Therapeutic Advances in Medical Oncology|June 21, 2019
CD8<sup>+</sup> PD-1<sup>+</sup> T-cells and PD-L1<sup>+</sup> circulating tumor cells in chemotherapy-naïve non-small cell lung cancer: towards their clinical relevance?Athanasios Kotsakis, Galatea Kallergi, Despoina Aggouraki, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2014
Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)Filippos Koinis, Aristidis Polyzos, Athina Christopoulou, et al.
Cancers|January 23, 2020
Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate CancerFilippos Koinis, Paul Corn, Nila Parikh, et al.
Plos One|July 19, 2017
Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancerIppokratis Messaritakis, Eleni Politaki, Athanasios Kotsakis, et al.
Cancer Chemotherapy and Pharmacology|August 11, 2018
Prognostic significance of CEACAM5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancerIppokratis Messaritakis, Maria Sfakianaki, Chara Papadaki, et al.
Cancer Chemotherapy and Pharmacology|January 30, 2021
Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(-) breast cancer receiving salvage treatment with everolimus/exemestaneMaria Spiliotaki, Galatea Kallergi, Christos Nikolaou, et al.
Pageof 4